Red Sun Pharmaceutical said on an interactive platform on September 9 that it is true that the Xuebijing injection reported by the media was included in the “Save Sepsis Campaign International Sepsis Guidelines”. Xuebijing injection is a new Class II traditional Chinese medicine approved domestically for treatment of sepsis and multiple organ dysfunction syndrome. Currently, there are no overseas sales of Xuebijing injections. The internationalization of Xuebijing injections is a long-term system project. Currently, it is still in the early stages of academic preparation, international certification, etc., and is still far from being officially commercialized in overseas markets.

Red Sun Pharmaceutical said on an interactive platform on September 9 that it is true that the Xuebijing injection reported by the media was included in the “Save Sepsis Campaign International Sepsis Guidelines”. Xuebijing injection is a new Class II traditional Chinese medicine approved domestically for treatment of sepsis and multiple organ dysfunction syndrome. Currently, there are no overseas sales of Xuebijing injections. The internationalization of Xuebijing injections is a long-term system project. Currently, it is still in the early stages of academic preparation, international certification, etc., and is still far from being officially commercialized in overseas markets.